Internet Delivered Cognitive Behavior Therapy Based on Intolerance of Uncertainty
NCT ID: NCT05820568
Last Updated: 2023-10-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
22 participants
INTERVENTIONAL
2022-11-02
2023-05-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
* Test the preliminary effect of the intervention in lowering symptoms of GAD as measured by the self report scale GAD-7
* Test procedures for recruitment, assessment, treatment and follow up
* Test the acceptability of the intervention as measured by the Client Satisfaction questionnaire-8, dropout and adverse events
Participants will apply for treatment in an online system, be assessed via video by a licensed clinical psychologist and then receive a 10 week long ICBT intervention based on the intolerance of uncertainty model. This is a pilot study for an upcoming randomized controlled trial.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Behavior Treatment of Older Adults With Generalized Anxiety Disorder in Primary Care
NCT00765219
Cognitive Behavior Therapy for Treating Anxiety in People With Dementia
NCT00596284
Cognitive Behavior Therapy for Health Anxiety: A Comparison of Three Forms of Self-help
NCT01966705
Internet-based Cognitive Behavioral Therapy (CBT) for Adolescents With Anxiety Disorders
NCT02535403
Internet-delivered Cognitive Behavioral Therapy (CBT) for Health Anxiety
NCT00828152
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Treatment
Patients receiving ICBT-IU
ICBT-IU
Internet delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder based on the Intolerance of uncertainty model of worry
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ICBT-IU
Internet delivered Cognitive Behavior Therapy for Generalized Anxiety Disorder based on the Intolerance of uncertainty model of worry
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of GAD based on clinical assessment.
* At least 10 points on GAD-7 at screening.
* Proficient in written Swedish.
* Access to internet enabled device and Swedish BankID for authentication
* Able to make sufficient time for the 10 week long treatment
* Consents to study
Exclusion Criteria
* Ongoing risk use of alcohol or drugs
* Ongoing serious somatic of social disease/problem that is deemed to be to much of a hindrance for the completion of the treatment
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Region Stockholm
OTHER_GOV
Karolinska Institutet
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Erik Forsell
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Internet Psychiatry Clinic, Psychiatry Southwest, SLSO, Region Stockholm
Stockholm, Huddinge, Sweden
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2022-02380-01-Pilot
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.